A Phase II, Safety and Efficacy Study of Inactivated EV 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants
Conditions
- The Study Focused on the Safety of Inactivated EV71 Vaccine (Human Diploid Cell) Against Hand, Foot and Mouth Disease in Chinese Children and Infants
Interventions
- BIOLOGICAL: 160Eu/0.5ml in infants (6-11 months old)
- BIOLOGICAL: 320Eu/0.5ml in infants (6-11 months old)
- BIOLOGICAL: 640Eu/0.5ml in infants (6-11 months old)
- BIOLOGICAL: 1280Eu/0.5ml (without adjuvant) in infants (6-11 months old)
- BIOLOGICAL: 0Eu/0.5ml in infants (6-11 months old)
- BIOLOGICAL: 160Eu/0.5ml in infants (12-23 months old)
- BIOLOGICAL: 320Eu/0.5ml in infants (12-23 months old)
- BIOLOGICAL: 640Eu/0.5ml in infants (12-23 months old)
- BIOLOGICAL: 1280Eu/0.5ml (without adjuvant) in infants (12-23 months old)
- BIOLOGICAL: 0Eu/0.5ml in infants (12-23 months old)
- BIOLOGICAL: 160Eu/0.5ml in children (24 months-5 years old)
- BIOLOGICAL: 320Eu/0.5ml in children (24 months-5 years old)
- BIOLOGICAL: 640Eu/0.5ml in children (24 months-5 years old)
- BIOLOGICAL: 1280Eu/0.5ml (without adjuvant) in children (24 months-5 years old)
- BIOLOGICAL: 0Eu/0.5ml in children (24 months-5 years old)
Sponsor
Institute of Medical Biology, Chinese Academy of Medical Sciences
Collaborators